US Stock Movement: Xeris Biopharma surged on October 5th due to acquisition interest, Phase III results for XP-8121, and revenue growth
Bitget异动解读2026/10/05 16:30Xeris Biopharma's Significant Surge on October 5 Explained
Keywords: acquisition interest, XP-8121 Phase III, revenue growth
1. On September 29, it was reported that H Lundbeck had been working with advisors to evaluate the possibility of acquiring Xeris. The discussions remain in the preliminary stages; Xeris stated that the company is "not for sale" and will continue to develop and commercialize its therapeutic product portfolio.
2. On September 9, the company stated that the registrational Phase III study plan for XP-8121 is scheduled to commence on time at the end of 2026, with primary results expected to be announced in the second half of 2028. FDA approval and commercialization in the United States is anticipated for 2030, with peak net revenue potential estimated between $1 billion and $3 billion.
3. On August 6, the company announced total revenue of $92.1 million for the second quarter, a 29% year-on-year increase; net product revenue reached $91 million, a 34% year-on-year increase. Among these, Recorlev’s net revenue was $56.8 million, up 81% year-on-year, and full-year total revenue guidance for 2026 was adjusted to $385 million to $390 million.
(Disclaimer: This content is generated by AI technology based on the summary of publicly available information, for reference only and does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Vance: The Alaska natural gas project will continue to move forward despite South Korea raising concerns about commercial viability.
(1) Although South Korea stated that its participation in the Alaska natural gas project depends on the project’s commercial viability, a move that prompted U.S. President Trump to threaten trade retaliation, U.S. Vice President Vance said the project will proceed. (2) On Monday, Vance said: “I believe this will definitely be achieved. Of course, some details still need to be finalized, and the South Korean side has already communicated regarding this.” (3) He added: “As long as there is market demand for these resources, and there is indeed strong demand for U.S. natural gas, I believe we will be able to complete this project.”
Singapore data center operator DayOne (DODC.US) applies for US listing, valuation may reach 20 billions USD
According to Jinse Finance, Singapore-based data center operator DayOne Data Centers submitted an F-1 registration statement to the U.S. Securities and Exchange Commission (SEC) on Monday, aiming for an initial public offering (IPO) of American Depositary Shares (ADS) on the Nasdaq Stock Market, with the ticker symbol “DODC.” DayOne plans to use the IPO proceeds to develop and construct new data center projects, as well as for working capital and other general corporate purposes. While DayOne has not disclosed the size of the offering, previous reports indicated the company plans to raise up to 5 billions USD, with a potential valuation reaching 20 billions USD.
Spot gold breaks through the $4,130/oz mark
Spot gold has just surpassed the $4,130.00 per ounce mark, last quoted at $4,129.95 per ounce, down 0.25% for the day; COMEX gold futures main contract last quoted at $4,157.20 per ounce, up 0.01% for the day.
In the past seven days, the average daily crude oil throughput in the Strait of Hormuz was 10.3 million barrels, only 76% of the pre-war level.
According to the latest data from market intelligence firm Kpler, as of Saturday, the average daily crude oil traffic through the Strait of Hormuz over the past seven days was 10.3 million barrels, which is only 76% of the pre-war baseline level.
